カテゴリー： LP Information, 世界, 医療/バイオ

豚コレラ生ワクチンのグローバル市場予測2023-2029

◆英語タイトル：Global Classical Swine Fever Live Vaccine Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23OT9014）◆商品コード：LP23OT9014
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年10月
◆ページ数：112
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「豚コレラ生ワクチンのグローバル市場」は、過去の販売実績から2022年の世界の豚コレラ生ワクチンの総販売量を検討し、2023年から2029年の予測される豚コレラ生ワクチンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の豚コレラ生ワクチンの市場規模を掲載し、XXX百万米ドル規模の世界の豚コレラ生ワクチン市場の詳細な分析を提供します。本インサイトレポートは、世界の豚コレラ生ワクチン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の豚コレラ生ワクチン市場における各社の独自のポジションをより深く理解するために、豚コレラ生ワクチン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の豚コレラ生ワクチン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。豚コレラ生ワクチンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。豚コレラ生ワクチンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。豚コレラ生ワクチンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

豚コレラ生ワクチンの世界主要メーカーとしては、WINSUN、 Boehringer Ingelheim、 CAHIC、 SPAH、 Merck、 Ceva、 Harbin Veterinary Research Institute、 Qilu Animal Health Products Factory、 Ringpu Biology、 DHN、 CAVAC、 Komipharm、 Agrovet、 Bioveta、 Jinyu Bio-Technology、 Institutul Pasteur、 MVP、 Teconなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の豚コレラ生ワクチン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では豚コレラ生ワクチン市場をセグメンテーションし、種類別 (組織培養由来、細胞株由来)、用途別 (市場販売、政府入札)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：組織培養由来、細胞株由来

・用途別区分：市場販売、政府入札

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の豚コレラ生ワクチン市場の10年間の市場状況・展望は？
・世界および地域別に見た豚コレラ生ワクチン市場成長の要因は何か？
・豚コレラ生ワクチンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・豚コレラ生ワクチンのタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：豚コレラ生ワクチンの年間販売量2018-2029、地域別現状・将来分析
・豚コレラ生ワクチンの種類別セグメント：組織培養由来、細胞株由来
・豚コレラ生ワクチンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・豚コレラ生ワクチンの用途別セグメント：市場販売、政府入札
・豚コレラ生ワクチンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の豚コレラ生ワクチン市場
・企業別のグローバル豚コレラ生ワクチン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の豚コレラ生ワクチンの年間売上：2018-2023年の売上、市場シェア
・企業別の豚コレラ生ワクチン販売価格
・主要企業の豚コレラ生ワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

豚コレラ生ワクチンの地域別レビュー
・地域別の豚コレラ生ワクチン市場規模2018-2023：年間販売量、売上
・主要国別の豚コレラ生ワクチン市場規模2018-2023：年間販売量、売上
・南北アメリカの豚コレラ生ワクチン販売の成長
・アジア太平洋の豚コレラ生ワクチン販売の成長
・ヨーロッパの豚コレラ生ワクチン販売の成長
・中東・アフリカの豚コレラ生ワクチン販売の成長

南北アメリカ市場
・南北アメリカの国別の豚コレラ生ワクチン販売量、売上（2018-2023）
・南北アメリカの豚コレラ生ワクチンの種類別販売量
・南北アメリカの豚コレラ生ワクチンの用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の豚コレラ生ワクチン販売量、売上（2018-2023）
・アジア太平洋の豚コレラ生ワクチンの種類別販売量
・アジア太平洋の豚コレラ生ワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の豚コレラ生ワクチン販売量、売上（2018-2023）
・ヨーロッパの豚コレラ生ワクチンの種類別販売量
・ヨーロッパの豚コレラ生ワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の豚コレラ生ワクチン販売量、売上（2018-2023）
・中東・アフリカの豚コレラ生ワクチンの種類別販売量
・中東・アフリカの豚コレラ生ワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・豚コレラ生ワクチンの製造コスト構造分析
・豚コレラ生ワクチンの製造プロセス分析
・豚コレラ生ワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・豚コレラ生ワクチンの主要なグローバル販売業者
・豚コレラ生ワクチンの主要なグローバル顧客

地域別の豚コレラ生ワクチン市場予測レビュー
・地域別の豚コレラ生ワクチン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・豚コレラ生ワクチンの種類別市場規模予測
・豚コレラ生ワクチンの用途別市場規模予測

主要企業分析
WINSUN、 Boehringer Ingelheim、 CAHIC、 SPAH、 Merck、 Ceva、 Harbin Veterinary Research Institute、 Qilu Animal Health Products Factory、 Ringpu Biology、 DHN、 CAVAC、 Komipharm、 Agrovet、 Bioveta、 Jinyu Bio-Technology、 Institutul Pasteur、 MVP、 Tecon
・企業情報
・豚コレラ生ワクチン製品
・豚コレラ生ワクチン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Classical Swine Fever Live Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Classical Swine Fever Live Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Classical Swine Fever Live Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Classical Swine Fever Live Vaccine Segment by Type
2.2.1 Tissue Culture Origin
2.2.2 Cell Line Origin
2.3 Classical Swine Fever Live Vaccine Sales by Type
2.3.1 Global Classical Swine Fever Live Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Classical Swine Fever Live Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Classical Swine Fever Live Vaccine Sale Price by Type (2018-2023)
2.4 Classical Swine Fever Live Vaccine Segment by Application
2.4.1 Market Sales
2.4.2 Government Tender
2.5 Classical Swine Fever Live Vaccine Sales by Application
2.5.1 Global Classical Swine Fever Live Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Classical Swine Fever Live Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Classical Swine Fever Live Vaccine Sale Price by Application (2018-2023)
3 Global Classical Swine Fever Live Vaccine by Company
3.1 Global Classical Swine Fever Live Vaccine Breakdown Data by Company
3.1.1 Global Classical Swine Fever Live Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Classical Swine Fever Live Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Classical Swine Fever Live Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Classical Swine Fever Live Vaccine Revenue by Company (2018-2023)
3.2.2 Global Classical Swine Fever Live Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Classical Swine Fever Live Vaccine Sale Price by Company
3.4 Key Manufacturers Classical Swine Fever Live Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Classical Swine Fever Live Vaccine Product Location Distribution
3.4.2 Players Classical Swine Fever Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Classical Swine Fever Live Vaccine by Geographic Region
4.1 World Historic Classical Swine Fever Live Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Classical Swine Fever Live Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Classical Swine Fever Live Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Classical Swine Fever Live Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Classical Swine Fever Live Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Classical Swine Fever Live Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Classical Swine Fever Live Vaccine Sales Growth
4.4 APAC Classical Swine Fever Live Vaccine Sales Growth
4.5 Europe Classical Swine Fever Live Vaccine Sales Growth
4.6 Middle East & Africa Classical Swine Fever Live Vaccine Sales Growth
5 Americas
5.1 Americas Classical Swine Fever Live Vaccine Sales by Country
5.1.1 Americas Classical Swine Fever Live Vaccine Sales by Country (2018-2023)
5.1.2 Americas Classical Swine Fever Live Vaccine Revenue by Country (2018-2023)
5.2 Americas Classical Swine Fever Live Vaccine Sales by Type
5.3 Americas Classical Swine Fever Live Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Classical Swine Fever Live Vaccine Sales by Region
6.1.1 APAC Classical Swine Fever Live Vaccine Sales by Region (2018-2023)
6.1.2 APAC Classical Swine Fever Live Vaccine Revenue by Region (2018-2023)
6.2 APAC Classical Swine Fever Live Vaccine Sales by Type
6.3 APAC Classical Swine Fever Live Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Classical Swine Fever Live Vaccine by Country
7.1.1 Europe Classical Swine Fever Live Vaccine Sales by Country (2018-2023)
7.1.2 Europe Classical Swine Fever Live Vaccine Revenue by Country (2018-2023)
7.2 Europe Classical Swine Fever Live Vaccine Sales by Type
7.3 Europe Classical Swine Fever Live Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Classical Swine Fever Live Vaccine by Country
8.1.1 Middle East & Africa Classical Swine Fever Live Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Classical Swine Fever Live Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Classical Swine Fever Live Vaccine Sales by Type
8.3 Middle East & Africa Classical Swine Fever Live Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Classical Swine Fever Live Vaccine
10.3 Manufacturing Process Analysis of Classical Swine Fever Live Vaccine
10.4 Industry Chain Structure of Classical Swine Fever Live Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Classical Swine Fever Live Vaccine Distributors
11.3 Classical Swine Fever Live Vaccine Customer
12 World Forecast Review for Classical Swine Fever Live Vaccine by Geographic Region
12.1 Global Classical Swine Fever Live Vaccine Market Size Forecast by Region
12.1.1 Global Classical Swine Fever Live Vaccine Forecast by Region (2024-2029)
12.1.2 Global Classical Swine Fever Live Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Classical Swine Fever Live Vaccine Forecast by Type
12.7 Global Classical Swine Fever Live Vaccine Forecast by Application
13 Key Players Analysis
13.1 WINSUN
13.1.1 WINSUN Company Information
13.1.2 WINSUN Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.1.3 WINSUN Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 WINSUN Main Business Overview
13.1.5 WINSUN Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 CAHIC
13.3.1 CAHIC Company Information
13.3.2 CAHIC Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.3.3 CAHIC Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 CAHIC Main Business Overview
13.3.5 CAHIC Latest Developments
13.4 SPAH
13.4.1 SPAH Company Information
13.4.2 SPAH Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.4.3 SPAH Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 SPAH Main Business Overview
13.4.5 SPAH Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.5.3 Merck Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
13.6 Ceva
13.6.1 Ceva Company Information
13.6.2 Ceva Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.6.3 Ceva Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ceva Main Business Overview
13.6.5 Ceva Latest Developments
13.7 Harbin Veterinary Research Institute
13.7.1 Harbin Veterinary Research Institute Company Information
13.7.2 Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.7.3 Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Harbin Veterinary Research Institute Main Business Overview
13.7.5 Harbin Veterinary Research Institute Latest Developments
13.8 Qilu Animal Health Products Factory
13.8.1 Qilu Animal Health Products Factory Company Information
13.8.2 Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.8.3 Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Qilu Animal Health Products Factory Main Business Overview
13.8.5 Qilu Animal Health Products Factory Latest Developments
13.9 Ringpu Biology
13.9.1 Ringpu Biology Company Information
13.9.2 Ringpu Biology Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.9.3 Ringpu Biology Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ringpu Biology Main Business Overview
13.9.5 Ringpu Biology Latest Developments
13.10 DHN
13.10.1 DHN Company Information
13.10.2 DHN Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.10.3 DHN Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 DHN Main Business Overview
13.10.5 DHN Latest Developments
13.11 CAVAC
13.11.1 CAVAC Company Information
13.11.2 CAVAC Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.11.3 CAVAC Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 CAVAC Main Business Overview
13.11.5 CAVAC Latest Developments
13.12 Komipharm
13.12.1 Komipharm Company Information
13.12.2 Komipharm Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.12.3 Komipharm Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Komipharm Main Business Overview
13.12.5 Komipharm Latest Developments
13.13 Agrovet
13.13.1 Agrovet Company Information
13.13.2 Agrovet Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.13.3 Agrovet Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Agrovet Main Business Overview
13.13.5 Agrovet Latest Developments
13.14 Bioveta
13.14.1 Bioveta Company Information
13.14.2 Bioveta Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.14.3 Bioveta Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Bioveta Main Business Overview
13.14.5 Bioveta Latest Developments
13.15 Jinyu Bio-Technology
13.15.1 Jinyu Bio-Technology Company Information
13.15.2 Jinyu Bio-Technology Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.15.3 Jinyu Bio-Technology Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Jinyu Bio-Technology Main Business Overview
13.15.5 Jinyu Bio-Technology Latest Developments
13.16 Institutul Pasteur
13.16.1 Institutul Pasteur Company Information
13.16.2 Institutul Pasteur Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.16.3 Institutul Pasteur Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Institutul Pasteur Main Business Overview
13.16.5 Institutul Pasteur Latest Developments
13.17 MVP
13.17.1 MVP Company Information
13.17.2 MVP Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.17.3 MVP Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 MVP Main Business Overview
13.17.5 MVP Latest Developments
13.18 Tecon
13.18.1 Tecon Company Information
13.18.2 Tecon Classical Swine Fever Live Vaccine Product Portfolios and Specifications
13.18.3 Tecon Classical Swine Fever Live Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Tecon Main Business Overview
13.18.5 Tecon Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Classical Swine Fever Live Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Classical Swine Fever Live Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tissue Culture Origin
Table 4. Major Players of Cell Line Origin
Table 5. Global Classical Swine Fever Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Classical Swine Fever Live Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Classical Swine Fever Live Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Classical Swine Fever Live Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Classical Swine Fever Live Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Classical Swine Fever Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Classical Swine Fever Live Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Classical Swine Fever Live Vaccine Revenue by Application (2018-2023)
Table 13. Global Classical Swine Fever Live Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Classical Swine Fever Live Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Classical Swine Fever Live Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Classical Swine Fever Live Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Classical Swine Fever Live Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Classical Swine Fever Live Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Classical Swine Fever Live Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Classical Swine Fever Live Vaccine Producing Area Distribution and Sales Area
Table 21. Players Classical Swine Fever Live Vaccine Products Offered
Table 22. Classical Swine Fever Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Classical Swine Fever Live Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Classical Swine Fever Live Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Classical Swine Fever Live Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Classical Swine Fever Live Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Classical Swine Fever Live Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Classical Swine Fever Live Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Classical Swine Fever Live Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Classical Swine Fever Live Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Classical Swine Fever Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Classical Swine Fever Live Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Classical Swine Fever Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Classical Swine Fever Live Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Classical Swine Fever Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Classical Swine Fever Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Classical Swine Fever Live Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Classical Swine Fever Live Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Classical Swine Fever Live Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Classical Swine Fever Live Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Classical Swine Fever Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Classical Swine Fever Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Classical Swine Fever Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Classical Swine Fever Live Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Classical Swine Fever Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Classical Swine Fever Live Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Classical Swine Fever Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Classical Swine Fever Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Classical Swine Fever Live Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Classical Swine Fever Live Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Classical Swine Fever Live Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Classical Swine Fever Live Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Classical Swine Fever Live Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Classical Swine Fever Live Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Classical Swine Fever Live Vaccine
Table 58. Key Market Challenges & Risks of Classical Swine Fever Live Vaccine
Table 59. Key Industry Trends of Classical Swine Fever Live Vaccine
Table 60. Classical Swine Fever Live Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Classical Swine Fever Live Vaccine Distributors List
Table 63. Classical Swine Fever Live Vaccine Customer List
Table 64. Global Classical Swine Fever Live Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Classical Swine Fever Live Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Classical Swine Fever Live Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Classical Swine Fever Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Classical Swine Fever Live Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Classical Swine Fever Live Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Classical Swine Fever Live Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Classical Swine Fever Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Classical Swine Fever Live Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Classical Swine Fever Live Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Classical Swine Fever Live Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Classical Swine Fever Live Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Classical Swine Fever Live Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Classical Swine Fever Live Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. WINSUN Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. WINSUN Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 80. WINSUN Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. WINSUN Main Business
Table 82. WINSUN Latest Developments
Table 83. Boehringer Ingelheim Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer Ingelheim Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 85. Boehringer Ingelheim Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Boehringer Ingelheim Main Business
Table 87. Boehringer Ingelheim Latest Developments
Table 88. CAHIC Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. CAHIC Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 90. CAHIC Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. CAHIC Main Business
Table 92. CAHIC Latest Developments
Table 93. SPAH Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. SPAH Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 95. SPAH Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. SPAH Main Business
Table 97. SPAH Latest Developments
Table 98. Merck Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 100. Merck Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Ceva Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Ceva Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 105. Ceva Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Ceva Main Business
Table 107. Ceva Latest Developments
Table 108. Harbin Veterinary Research Institute Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 110. Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Harbin Veterinary Research Institute Main Business
Table 112. Harbin Veterinary Research Institute Latest Developments
Table 113. Qilu Animal Health Products Factory Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 115. Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Qilu Animal Health Products Factory Main Business
Table 117. Qilu Animal Health Products Factory Latest Developments
Table 118. Ringpu Biology Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Ringpu Biology Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 120. Ringpu Biology Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Ringpu Biology Main Business
Table 122. Ringpu Biology Latest Developments
Table 123. DHN Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. DHN Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 125. DHN Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. DHN Main Business
Table 127. DHN Latest Developments
Table 128. CAVAC Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. CAVAC Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 130. CAVAC Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. CAVAC Main Business
Table 132. CAVAC Latest Developments
Table 133. Komipharm Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Komipharm Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 135. Komipharm Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Komipharm Main Business
Table 137. Komipharm Latest Developments
Table 138. Agrovet Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Agrovet Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 140. Agrovet Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Agrovet Main Business
Table 142. Agrovet Latest Developments
Table 143. Bioveta Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. Bioveta Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 145. Bioveta Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Bioveta Main Business
Table 147. Bioveta Latest Developments
Table 148. Jinyu Bio-Technology Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Jinyu Bio-Technology Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 150. Jinyu Bio-Technology Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Jinyu Bio-Technology Main Business
Table 152. Jinyu Bio-Technology Latest Developments
Table 153. Institutul Pasteur Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Institutul Pasteur Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 155. Institutul Pasteur Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Institutul Pasteur Main Business
Table 157. Institutul Pasteur Latest Developments
Table 158. MVP Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. MVP Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 160. MVP Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. MVP Main Business
Table 162. MVP Latest Developments
Table 163. Tecon Basic Information, Classical Swine Fever Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 164. Tecon Classical Swine Fever Live Vaccine Product Portfolios and Specifications
Table 165. Tecon Classical Swine Fever Live Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Tecon Main Business
Table 167. Tecon Latest Developments
List of Figures
Figure 1. Picture of Classical Swine Fever Live Vaccine
Figure 2. Classical Swine Fever Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Classical Swine Fever Live Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Classical Swine Fever Live Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Classical Swine Fever Live Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tissue Culture Origin
Figure 10. Product Picture of Cell Line Origin
Figure 11. Global Classical Swine Fever Live Vaccine Sales Market Share by Type in 2022
Figure 12. Global Classical Swine Fever Live Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Classical Swine Fever Live Vaccine Consumed in Market Sales
Figure 14. Global Classical Swine Fever Live Vaccine Market: Market Sales (2018-2023) & (K Units)
Figure 15. Classical Swine Fever Live Vaccine Consumed in Government Tender
Figure 16. Global Classical Swine Fever Live Vaccine Market: Government Tender (2018-2023) & (K Units)
Figure 17. Global Classical Swine Fever Live Vaccine Sales Market Share by Application (2022)
Figure 18. Global Classical Swine Fever Live Vaccine Revenue Market Share by Application in 2022
Figure 19. Classical Swine Fever Live Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Classical Swine Fever Live Vaccine Sales Market Share by Company in 2022
Figure 21. Classical Swine Fever Live Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Classical Swine Fever Live Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Classical Swine Fever Live Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Classical Swine Fever Live Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Classical Swine Fever Live Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Classical Swine Fever Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Classical Swine Fever Live Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Classical Swine Fever Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Classical Swine Fever Live Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Classical Swine Fever Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Classical Swine Fever Live Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Classical Swine Fever Live Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Classical Swine Fever Live Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Classical Swine Fever Live Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Classical Swine Fever Live Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Classical Swine Fever Live Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Classical Swine Fever Live Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Classical Swine Fever Live Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Classical Swine Fever Live Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Classical Swine Fever Live Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Classical Swine Fever Live Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Classical Swine Fever Live Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Classical Swine Fever Live Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Classical Swine Fever Live Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Classical Swine Fever Live Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Classical Swine Fever Live Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Classical Swine Fever Live Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Classical Swine Fever Live Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Classical Swine Fever Live Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Classical Swine Fever Live Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Classical Swine Fever Live Vaccine
Figure 72. Industry Chain Structure of Classical Swine Fever Live Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Classical Swine Fever Live Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Classical Swine Fever Live Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Classical Swine Fever Live Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Classical Swine Fever Live Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Classical Swine Fever Live Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Classical Swine Fever Live Vaccine Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 豚コレラ生ワクチンのグローバル市場予測2023-2029(Global Classical Swine Fever Live Vaccine Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 弱毒化帯状疱疹生ワクチンのグローバル市場予測2023-2029
  • 生ワクチン&弱毒化ワクチンのグローバル市場予測2023-2029

    • ◆H&Iグローバルリサーチのお客様（例）◆